Varian ProBeam 360 Proton Therapy System Selected by Penn Medicine for Use in Second Treatment ...

Palo Alto, Calif., Oct. 23, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has been selected by Penn Medicine to install a Varian ProBeam® 360° proton therapy system in a single-room configuration at Lancaster General Health Ann B. Barshinger Cancer Institute in south central Pennsylvania. In addition to the equipment, Varian will also provide its ARIA® information management system and Eclipse™ treatment planning system. Construction of the...This story is related to the following:Electrotherapy Equipment
Source: Industrial Newsroom - Health, Medical and Dental Supplies - Category: Medical Devices Source Type: news